MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Are GBA–Parkinson Disease patients’ good candidates for Deep Brain Stimulation? A Longitudinal Multicentric study on a Large Italian Cohort

    M. Avenali, R. Zangaglia, G. Cuconato, I. Palmieri, A. Albanese, CA. Artusi, M. Bozzali, F. Cavallieri, R. Cilia, A. Cocco, R. Eleopra, A. Imarisio, G. Imbalzano, C. Ledda, L. Lopiano, M. Malaguti, F. Mameli, P. Mitrotti, F. Spagnolo, C. Tassorelli, F. Valentino, F. Valzania, A. Di Fonzo, C. Pacchetti, EM. Valente (Pavia, Italy)

    Objective: To investigate the impact of GBA variants on the long-term outcome of deep brain stimulation (DBS) in a large cohort of Italian PD subjects…
  • 2023 International Congress

    Istradefylline effect on Parkinson’s Disease Tremor, Motor symptoms and non-Motor symptoms.

    K. Chandrakumar, B. Wilmarth, B. Nagle, G. Di Maria, O. Gonul, L. Lovelace, E. Waldon, K. Getchell, Y. Torres-Yaghi, F. Pagan (Washington, USA)

    Objective: Istradefylline is FDA approved for use in patients with PD treated with carbidopa-levodopa to reduce off time. GUH Movement Disorder Group has observed that…
  • 2023 International Congress

    Gene-environment interactions for Parkinson’s disease

    R. Torricelli, A. Reynoso, B. Jacobs, J. Shi, S. Aslibekyan, L. Kaufmann, A. Noyce, K. Heilbron (London, United Kingdom)

    Objective: The aim of this study was to test for interactions between PD-related genetic and phenotypic traits in the 23andMe, Inc. research cohort. Background: Parkinson’s…
  • 2023 International Congress

    Multiple N-of-1 trials to investigate hypoxia-based treatment in Parkinson’s disease: safety and short-term effects

    J. Janssen Daalen, M. Meinders, F. Giardina, S. Mathur, P. Ainslie, D. Thijssen, B. Bloem (Nijmegen, Netherlands)

    Objective: In this study, we describe the safety and short-term effects of the first hypoxia-based treatment trial in Parkinson’s disease by deploying a personalized multiple…
  • 2023 International Congress

    An IMU- based Objective Quantification Method for Bradykinesia Evaluation in Parkinson’s disease

    Y. Wu, H. Yu, Y. Fan, G. Zhang, L. Guan, H. Hao, L. Li (Beijing, China)

    Objective: Proposing an inertial measurement unit (IMU)-based objective quantification method for bradykinesia evaluation in Parkinson’s disease (PD) using MDS UPDRS III. Background: MDS-UPDRS III rating…
  • 2023 International Congress

    Efficacy of subthalamic nucleus deep brain stimulation in Parkinson’s disease: A preliminary Thailand experience

    S. Rujirussawarawong, C. Kasemsuk, T. Srikijvilaikul, N. Limotai (ฺฺBangkok, Thailand)

    Objective: To evaluate the efficacy and adverse events of subthalamic nucleus deep brain stimulation (STN-DBS) in Thai patients with Parkinson’s disease (PD). Background: Bilateral STN-DBS…
  • 2023 International Congress

    Parkinsonian tremor secondary to Sinking flap syndrome – An atypical presentation

    R. Kota, K. Garg, M. Singh, R. Rajan (NEW DELHI, India)

    Objective: The association of sinking flap syndrome with Parkinsonian tremors is very rare Background: The association of sinking flap syndrome with Parkinsonian tremors is very…
  • 2023 International Congress

    Validation of the Japanese version of the King’s Parkinson’s Disease Pain Scale and the King’s Parkinson’s Disease Pain Questionnaire

    K. Kurihara, S. Zfujioka, T. Mishima, Y. Tsuboi (Fukuoka, Japan)

    Objective: The purpose of this study is a validation of the Japanese version of the King's Parkinson's Disease Pain Scale (KPPS) and the King's Parkinson's…
  • 2023 International Congress

    Building and evaluating a speech biomarker from 2-seconds sustained phonation to detect and monitor Parkinson’s disease

    J. Tröger, L. Schwed, E. Baykara, N. Linz, J. Orozco-Arroyave (Saarbrücken, Germany)

    Objective: The aim of this work was to evaluate the feasibility of a speech-based algorithm geared towards frequent remote measuring of Parkinson’s disease severity with…
  • 2023 International Congress

    Dopamine dysregulation syndrome in Parkinson’s disease controlled by safinamine

    SK. Song, JH. Kang (Jeju-Si, Republic of Korea)

    Objective: To describe a case of dopamine dysregulation syndrome managed by safinamide. Background: Dopamine dysregulation syndrome (DDS) is an uncommon non-motor symptom of Parkinson disease…
  • « Previous Page
  • 1
  • …
  • 100
  • 101
  • 102
  • 103
  • 104
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley